Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-03-23 4:54 pm | N/A 2035-12-01 | Autolus Therapeutics plc | AUTL | Richardson Ryan Director | 0 | $0 | 80,000 (Direct) | View |
Ownership | 2026-03-18 8:40 pm | N/A 2035-10-08 | Autolus Therapeutics plc | AUTL | Piccina Cintia U.S. CCO & Country Gen Manager | 0 | $0 | 761,000 (Direct) | View |
Ownership | 2026-03-18 8:01 pm | N/A N/A | Autolus Therapeutics plc | AUTL | BUTITTA CYNTHIA M Director | 0 | $0 | 392,095 (Direct) | View |
Ownership | 2026-03-18 8:00 pm | N/A 2033-12-20 | Autolus Therapeutics plc | AUTL | Leiderman Elisabeth Director | 0 | $0 | 240,000 (Direct) | View |
Ownership | 2026-03-18 7:59 pm | N/A 2034-09-30 | Autolus Therapeutics plc | AUTL | Will Matthias Chief Development Officer | 0 | $0 | 1,508,300 (Direct) | View |
Ownership | 2026-03-18 7:58 pm | N/A 2031-11-06 | Autolus Therapeutics plc | AUTL | YOUNG WILLIAM D Director | 0 | $0 | 310,000 (Direct) | View |
Ownership | 2026-03-18 7:57 pm | N/A 2034-01-09 | Autolus Therapeutics plc | AUTL | Azelby Robert Director | 0 | $0 | 240,000 (Direct) | View |
Ownership | 2026-03-18 7:56 pm | N/A 2034-04-01 | Autolus Therapeutics plc | AUTL | Rao Madduri Ravin Director | 0 | $0 | 240,000 (Direct) | View |
Ownership | 2026-03-18 7:55 pm | N/A 2034-04-01 | Autolus Therapeutics plc | AUTL | BONNEY MICHAEL W Director | 0 | $0 | 280,000 (Direct) | View |
Ownership | 2026-03-18 7:55 pm | N/A 2035-10-08 | Autolus Therapeutics plc | AUTL | McIlvenny Patrick Paul SVP Finance | 0 | $0 | 331,000 (Direct) | View |
Ownership | 2026-03-18 7:54 pm | N/A 2033-07-17 | Autolus Therapeutics plc | AUTL | Dolski Robert Chief Financial Officer | 0 | $0 | 1,508,300 (Direct) | View |
Ownership | 2026-03-18 7:53 pm | N/A 2028-06-21 | Autolus Therapeutics plc | AUTL | Bain Linda Director | 0 | $0 | 366,397 (Direct) | View |
Ownership | 2026-03-18 7:52 pm | N/A 2033-06-30 | Autolus Therapeutics plc | AUTL | Iannone Robert Director | 0 | $0 | 265,000 (Direct) | View |
Ownership | 2026-03-18 7:51 pm | N/A N/A | Autolus Therapeutics plc | AUTL | Berriman John E Director | 0 | $0 | 487,029 (Direct) | View |
Ownership | 2026-03-18 7:50 pm | N/A N/A | Autolus Therapeutics plc | AUTL | Itin Christian Chief Executive Officer | 0 | $0 | 6,917,877 (Direct) | View |
Ownership | 2026-03-18 7:49 pm | N/A 2027-04-21 | Autolus Therapeutics plc | AUTL | Pule Martin Anton Director | 0 | $0 | 1,438,262 (Direct) | View |
Ownership | 2026-03-18 7:48 pm | N/A N/A | Autolus Therapeutics plc | AUTL | Vann Christopher Andrew Chief Operating Officer | 0 | $0 | 2,274,467 (Direct) | View |
Ownership | 2026-03-18 7:48 pm | N/A N/A | Autolus Therapeutics plc | AUTL | Williams Christopher Michael James Chief Business Officer | 0 | $0 | 1,625,989 (Direct) | View |
Ownership | 2026-03-18 7:47 pm | N/A N/A | Autolus Therapeutics plc | AUTL | Swan Alexander Chief Human Resources Officer | 0 | $0 | 1,784,319 (Direct) | View |
Ownership | 2026-03-18 7:46 pm | N/A N/A | Autolus Therapeutics plc | AUTL | Driggs Alex SVP, Legal Affairs and GC | 0 | $0 | 780,818 (Direct) | View |
Ownership | 2026-03-18 7:45 pm | N/A N/A | Autolus Therapeutics plc | AUTL | Neville Miranda Suzette Chief Technology Officer | 0 | $0 | 1,539,020 (Direct) | View |